GAD1 and type 1 diabetes mellitus: To test the activity of GAD-BPI, a T1D mouse model was developed by administration of the GAD208–217 peptide (40 nmol) in complete Freund’s adjuvant (CFA) via subcutaneous (s.c.)route.